Quick Takeaways
- Thomas Templeman has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,498,422.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Thomas Templeman
- Location
- Cheshire, United Kingdom
- Summary
- The estimated net worth of Thomas Templeman is at least $1,498,422 dollars as of 04 Apr 2023. Thomas Templeman is the Chief Technology Officer of Centessa Pharmaceuticals plc and owns shares of Centessa Pharmaceuticals plc (CNTA) stock worth about $1.5M.
- Signature
- /s/ Gregory Weinhoff, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Thomas Templeman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Centessa Pharmaceuticals plc ($1,498,422).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Thomas Templeman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | Chief Technology Officer | $1,498,422 | 31 Mar 2023 |
Insider Transactions Reported by Thomas Templeman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.